Page last updated: 2024-08-26

n-methylglycinamide and sarcosine

n-methylglycinamide has been researched along with sarcosine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19904 (57.14)18.7374
1990's3 (42.86)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bramson, JL; Malapetsa, A; Noë, AJ; Panasci, LC1
Feindel, W; Panasci, LC; Skalski, V2
de Certaines, JD; Higuchi, T; Hirakawa, K; Le Moyec, L; Naruse, S; Roques, BP; Watari, H1
Benabib, AL; Chatel, M; Darcel, F; de Certaines, JD; François, A; Le Moyec, L; Le Rumeur, E; Lotito, S; Remy, C1
Blaney, JM; Crippen, GM; Havel, TF; Kuntz, ID1
Marcantonio, D; Noë, AJ; Panasci, LC1

Other Studies

7 other study(ies) available for n-methylglycinamide and sarcosine

ArticleYear
Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblasts.
    Cancer chemotherapy and pharmacology, 1992, Volume: 31, Issue:2

    Topics: Biological Transport; Colonic Neoplasms; Drug Carriers; Epinephrine; Fibroblasts; Humans; Lung Neoplasms; Sarcosine; Tumor Cells, Cultured

1992
Transport of amino acid amide sarcosinamide and sarcosinamide chloroethylnitrosourea in human glioma SK-MG-1 cells.
    Cancer research, 1990, May-15, Volume: 50, Issue:10

    Topics: Biological Transport, Active; Carmustine; Glioma; Glycine; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Sarcosine; Sodium; Structure-Activity Relationship; Tumor Cells, Cultured

1990
In vivo 31P MRS in new antineoplastic agents evaluation on experimental tumor models.
    Cancer biochemistry biophysics, 1988, Volume: 10, Issue:1

    Topics: Animals; Antineoplastic Agents; Carbazoles; Carcinoma 256, Walker; Energy Metabolism; Female; Glioma; Glycine; Magnetic Resonance Spectroscopy; Phosphorus; Rats; Rats, Inbred Strains; Sarcosine

1988
The cytotoxicity of a 2-chloroethylnitrosourea analog of sarcosinamide in the SK-MG-1 human glioma cell line as a possible indicator for transport.
    Journal of neuro-oncology, 1989, Volume: 7, Issue:2

    Topics: Antineoplastic Agents; Biological Transport; Brain Neoplasms; Carmustine; Cell Line; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glioma; Humans; Sarcosine; Tritium; Tumor Cells, Cultured

1989
Limits of tumour treatment follow up by surface coil 31P magnetic resonance spectroscopy. The case of sarcosinamide-CNU treated ependymoblastoma.
    NMR in biomedicine, 1989, Volume: 2, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Ependymoma; Ethylnitrosourea; Follow-Up Studies; Magnetic Resonance Spectroscopy; Mice; Sarcosine

1989
The combinatorial distance geometry method for the calculation of molecular conformation. II. Sample problems and computational statistics.
    Journal of theoretical biology, 1983, Oct-07, Volume: 104, Issue:3

    Topics: Computers; Cycloparaffins; Gonadotropin-Releasing Hormone; Mathematics; Models, Chemical; Molecular Conformation; Sarcosine

1983
SarCNU (2-chloroethyl-3-sarcosinamide-1-nitrosourea): a novel analogue of chloroethylnitrosourea that is transported by the catecholamine uptake2 carrier, which mediates increased cytotoxicity.
    Cancer chemotherapy and pharmacology, 1996, Volume: 37, Issue:6

    Topics: Biological Transport; Carmustine; Carrier Proteins; Catecholamine Plasma Membrane Transport Proteins; Catecholamines; Humans; Membrane Transport Proteins; Sarcosine; Tumor Cells, Cultured

1996